Carnegie Mellon University is an investment fund managing more than $73.9 billion ran by Charles Kennedy. There are currently 4 companies in Mr. Kennedy’s portfolio. The largest investments include Duolingo and Carmell Corporation, together worth $73.9 billion.
As of 1st August 2024, Carnegie Mellon University’s top holding is 353,314 shares of Duolingo currently worth over $73.7 billion and making up 99.8% of the portfolio value.
Relative to the number of outstanding shares of Duolingo, Carnegie Mellon University owns more than approximately 0.1% of the company.
In addition, the fund holds 103,061 shares of Carmell Corporation worth $137 million.
The third-largest holding is Innsuites Hospitality Trust worth $17.8 million and the next is Predictive Oncology worth $10.8 million, with 10,358 shares owned.
Currently, Carnegie Mellon University's portfolio is worth at least $73.9 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Carnegie Mellon University office and employees reside in Pittsburgh, Pennsylvania. According to the last 13-F report filed with the SEC, Charles Kennedy serves as the Chief Investment Officer at Carnegie Mellon University.
There are companies that Carnegie Mellon University is getting rid of from its portfolio.
Carnegie Mellon University closed its position in Vera Therapeutics Inc on 8th August 2024.
It sold the previously owned 16,060 shares for $693 million.
Charles Kennedy also disclosed a decreased stake in Duolingo by approximately 0.1%.
This leaves the value of the investment at $73.7 billion and 353,314 shares.
The two most similar investment funds to Carnegie Mellon University are Idg Technology Venture Investment Iv and Keyframe Capital Partners, L.P.. They manage $74 billion and $73.8 billion respectively.
Carnegie Mellon University’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Technology — making up 99.8% of
the total portfolio value.
The fund focuses on investments in the United States as
75.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
50% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $940 million.
These positions were updated on August 8th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Duolingo, Inc. |
1.40%
353,314
|
$73,726,032,000 | 99.78% |
| Vera Therapeutics Inc |
Closed
16,060
|
$692,507,000 | |
| Carmell Corporation |
No change
103,061
|
$137,071,000 | 0.19% |
| NeuBase Therapeutics, Inc. |
Closed
46,970
|
$21,132,000 | |
| Innsuites Hospitality Trust |
No change
10,000
|
$17,800,000 | 0.02% |
| Predictive Oncology Inc. |
No change
10,358
|
$10,772,000 | 0.01% |
| No transactions found | |||
| Showing first 500 out of 6 holdings | |||